Native rhIGF-1 in IGF-1 Deficiency Chernausek et al., Journal of Clinical Endocrinology & Metabolism (2007) Chernausek and colleagues conducted the pivotal long-term clinical trial of recombinant human IGF-1 (mecasermin) in pediatric patients with severe primary IGF-1 deficiency the trial that supported FDA approval of Increlex for this rare growth-failure population
Ipamorelin works by increasing natural growth hormone pulses, which can cause fluid shifts (leading to bloating or joint aches)
INGREDIENTS: Water, l-carnitine base, acidity regulator: citric acid, vitamins A, E, W, flavoring, sweeteners: sucralose, stevia, preservatives: sodium benzoate, potassium sorbate, selenium
Not Recommended During Pregnancy GLP-1 medications are generally not recommended for use during pregnancy
Tirzepatide, available as injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) or oral (at $349/mo month-to-month, or from $279/mo on the 6-month plan), targets both GLP-1 and GIP receptors and may produce greater weight loss and cholesterol improvements than semaglutide alone
This date is often shorter than branded equivalents because compounded preparations might not contain the same long-term preservatives